These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 35812139)

  • 41. TLRs regulate the gatekeeping functions of the intestinal follicle-associated epithelium.
    Chabot S; Wagner JS; Farrant S; Neutra MR
    J Immunol; 2006 Apr; 176(7):4275-83. PubMed ID: 16547265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of antibody responses of local lymph nodes to antigen given under the oral submucosa.
    Aoyama-Kondo T; Yoshida T; Tsobe K; Nakayama A; Asai J; Oka T; Nakashima I
    Immunobiology; 1992 Apr; 184(4-5):372-83. PubMed ID: 1592428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral Vaccination Through Peyer's Patches: Update on Particle Uptake.
    Pais Soares EF; Fernandes Borges OM
    Curr Drug Deliv; 2018; 15(3):321-330. PubMed ID: 28847272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
    Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
    Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent strategies driving oral biologic administration.
    Alotaibi BS; Buabeid M; Ibrahim NA; Kharaba ZJ; Ijaz M; Murtaza G
    Expert Rev Vaccines; 2021 Dec; 20(12):1587-1601. PubMed ID: 34612121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is there evidence that the gut contributes to mucosal immunity in humans?
    Kang W; Kudsk KA
    JPEN J Parenter Enteral Nutr; 2007; 31(3):246-58. PubMed ID: 17463152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of a mouse ligated Peyer’s patch intestinal loop assay to evaluate bacterial uptake by M cells.
    Fukuda S; Hase K; Ohno H
    J Vis Exp; 2011 Dec; (58):. PubMed ID: 22215009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ileal and jejunal Peyer's patches play distinct roles in mucosal immunity of sheep.
    Mutwiri G; Watts T; Lew L; Beskorwayne T; Papp Z; Baca-Estrada ME; Griebel P
    Immunology; 1999 Jul; 97(3):455-61. PubMed ID: 10447767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peyer's patches are required for the induction of rapid Th1 responses in the gut and mesenteric lymph nodes during an enteric infection.
    Kwa SF; Beverley P; Smith AL
    J Immunol; 2006 Jun; 176(12):7533-41. PubMed ID: 16751400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Oral vaccination and vaccine-entrapped microparticle delivery system].
    Li FQ; Fei YB; Su H; Hu JH
    Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chitosan for mucosal vaccination.
    van der Lubben IM; Verhoef JC; Borchard G; Junginger HE
    Adv Drug Deliv Rev; 2001 Nov; 52(2):139-44. PubMed ID: 11718937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peyer's patches are required for intestinal immunoglobulin A responses to Salmonella spp.
    Hashizume T; Togawa A; Nochi T; Igarashi O; Kweon MN; Kiyono H; Yamamoto M
    Infect Immun; 2008 Mar; 76(3):927-34. PubMed ID: 18086815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice.
    Gonnella PA; Chen Y; Inobe J; Komagata Y; Quartulli M; Weiner HL
    J Immunol; 1998 May; 160(10):4708-18. PubMed ID: 9590216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mucosal immune system: From dentistry to vaccine development.
    Kiyono H; Azegami T
    Proc Jpn Acad Ser B Phys Biol Sci; 2015; 91(8):423-39. PubMed ID: 26460320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)-Structure, function and species differences.
    Pabst R
    Vaccine; 2015 Aug; 33(36):4406-13. PubMed ID: 26196324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting to intestinal M cells.
    Jepson MA; Clark MA; Foster N; Mason CM; Bennett MK; Simmons NL; Hirst BH
    J Anat; 1996 Dec; 189 ( Pt 3)(Pt 3):507-16. PubMed ID: 8982824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses.
    Ibañez AE; Coria LM; Carabajal MV; Delpino MV; Risso GS; Cobiello PG; Rinaldi J; Barrionuevo P; Bruno L; Frank F; Klinke S; Goldbaum FA; Briones G; Giambartolomei GH; Pasquevich KA; Cassataro J
    J Control Release; 2015 Dec; 220(Pt A):18-28. PubMed ID: 26456256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response.
    Aljurayyan A; Puksuriwong S; Ahmed M; Sharma R; Krishnan M; Sood S; Davies K; Rajashekar D; Leong S; McNamara PS; Gordon S; Zhang Q
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.
    Chamcha V; Jones A; Quigley BR; Scott JR; Amara RR
    J Immunol; 2015 Nov; 195(10):5025-34. PubMed ID: 26482408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. M-cell targeted polymeric lipid nanoparticles containing a Toll-like receptor agonist to boost oral immunity.
    Ma T; Wang L; Yang T; Ma G; Wang S
    Int J Pharm; 2014 Oct; 473(1-2):296-303. PubMed ID: 24984067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.